• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

SGI rolls out new Octane workstation

Article

Silicon Graphics of Mountain View, CA, last month debuted a newmid-range desktop workstation designed to take the place of itsIndigo2 Impact product. The new computer line, Octane, can beused for computationally intensive applications like medical

Silicon Graphics of Mountain View, CA, last month debuted a newmid-range desktop workstation designed to take the place of itsIndigo2 Impact product. The new computer line, Octane, can beused for computationally intensive applications like medical simulation,advanced image processing, and surgical planning and treatment.

Octane replaces Indigo2 Impact's conventional shared bus witha crossbar-switch architecture that allows data to move more quicklybetween components on the computer's motherboard. SGI implementeda crossbar-like architecture on its entry-level O2 workstation,which was introduced in October (SCAN 10/23/96).

In addition to the single-processor system, Octane is availablein a dual-processor configuration, which boosts the system's processingpower, according to Eric Lindquist, medical market manager.

Octane will carry the same list price as Indigo2 Impact did, startingat $25,000, while the price of Indigo2 Impact has been cut, Lindquistsaid.

Recent Videos
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Detecting PCa Recurrence in African Americans: Can 18F-Flotufolastat Have an Impact?
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Related Content
© 2024 MJH Life Sciences

All rights reserved.